Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 109

1.

Effect of SGLT2 inhibitors on body composition, fluid status and renin-angiotensin-aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy.

Schork A, Saynisch J, Vosseler A, Jaghutriz BA, Heyne N, Peter A, Häring HU, Stefan N, Fritsche A, Artunc F.

Cardiovasc Diabetol. 2019 Apr 5;18(1):46. doi: 10.1186/s12933-019-0852-y.

2.

Sex-Specific Associations of Testosterone With Metabolic Traits.

Lutz SZ, Wagner R, Fritsche L, Peter A, Rettig I, Willmann C, Fehlert E, Martus P, Todenhöfer T, Stefan N, Fritsche A, Häring HU, Heni M.

Front Endocrinol (Lausanne). 2019 Mar 13;10:90. doi: 10.3389/fendo.2019.00090. eCollection 2019.

3.

Performance of a novel high sensitivity cardiac troponin I assay in asymptomatic hemodialysis patients - evidence for sex-specific differences.

Artunc F, Haag S, Friedrich B, Mueller C, Häring HU, Peter A.

Clin Chem Lab Med. 2019 Mar 20. pii: /j/cclm.ahead-of-print/cclm-2018-1176/cclm-2018-1176.xml. doi: 10.1515/cclm-2018-1176. [Epub ahead of print]

PMID:
30893052
4.

Gene x Gene Interactions Highlight the Role of Incretin Resistance for Insulin Secretion.

Jaghutriz BA, Heni M, Lutz SZ, Fritsche L, Machicao F, Staiger H, Peter A, Häring HU, Fritsche A, Wagner R.

Front Endocrinol (Lausanne). 2019 Feb 21;10:72. doi: 10.3389/fendo.2019.00072. eCollection 2019.

5.

Harmonization of immunoassays for biomarkers in diabetes mellitus.

Hörber S, Achenbach P, Schleicher E, Peter A.

Biotechnol Adv. 2019 Feb 23. pii: S0734-9750(19)30034-5. doi: 10.1016/j.biotechadv.2019.02.015. [Epub ahead of print] Review.

6.

The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet.

Lutz SZ, Hennige AM, Peter A, Kovarova M, Totsikas C, Machann J, Kröber SM, Sperl B, Schleicher E, Schick F, Heni M, Ullrich A, Häring HU, Stefan N.

J Clin Endocrinol Metab. 2019 Jun 1;104(6):2041-2053. doi: 10.1210/jc.2018-01573.

PMID:
30541128
7.

Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis.

Ebner M, Birschmann I, Peter A, Härtig F, Spencer C, Kuhn J, Rupp A, Blumenstock G, Zuern CS, Ziemann U, Poli S.

J Am Heart Assoc. 2018 Oct 2;7(19):e009807. doi: 10.1161/JAHA.118.009807.

8.

Unusual high blood glucose in ketoacidosis as first presentation of type 1 diabetes mellitus

Hörber S, Hudak S, Kächele M, Overkamp D, Fritsche A, Häring HU, Peter A, Heni M.

Endocrinol Diabetes Metab Case Rep. 2018 Sep 25;2018. doi: 10.1530/EDM-18-0094.

9.

Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible Explanation.

Franko A, Merkel D, Kovarova M, Hoene M, Jaghutriz BA, Heni M, Königsrainer A, Papan C, Lehr S, Häring HU, Peter A.

Nutrients. 2018 Sep 17;10(9). pii: E1314. doi: 10.3390/nu10091314.

10.

The Expression of Aldolase B in Islets Is Negatively Associated With Insulin Secretion in Humans.

Gerst F, Jaghutriz BA, Staiger H, Schulte AM, Lorza-Gil E, Kaiser G, Panse M, Haug S, Heni M, Schütz M, Stadion M, Schürmann A, Marzetta F, Ibberson M, Sipos B, Fend F, Fleming T, Nawroth PP, Königsrainer A, Nadalin S, Wagner S, Peter A, Fritsche A, Richter D, Solimena M, Häring HU, Ullrich S, Wagner R.

J Clin Endocrinol Metab. 2018 Dec 1;103(12):4373-4383. doi: 10.1210/jc.2018-00791.

PMID:
30202879
11.

cGMP-dependent protein kinase I (cGKI) modulates human hepatic stellate cell activation.

Franko A, Kovarova M, Feil S, Feil R, Wagner R, Heni M, Königsrainer A, Ruoß M, Nüssler AK, Weigert C, Häring HU, Lutz SZ, Peter A.

Metabolism. 2018 Nov;88:22-30. doi: 10.1016/j.metabol.2018.09.001. Epub 2018 Sep 6.

12.

Intensifying sleep slow oscillations does not improve metabolic control in healthy men.

Santiago JCP, Ngo HV, Jickeli C, Peter A, Hallschmid M.

Psychoneuroendocrinology. 2019 Jan;99:1-7. doi: 10.1016/j.psyneuen.2018.08.028. Epub 2018 Aug 23.

PMID:
30172070
13.

BMI-Independent Effects of Gestational Diabetes on Human Placenta.

Stirm L, Kovárová M, Perschbacher S, Michlmaier R, Fritsche L, Siegel-Axel D, Schleicher E, Peter A, Pauluschke-Fröhlich J, Brucker S, Abele H, Wallwiener D, Preissl H, Wadsack C, Häring HU, Fritsche A, Ensenauer R, Desoye G, Staiger H.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3299-3309. doi: 10.1210/jc.2018-00397.

PMID:
29931171
14.

Towards a Sustainable Synthesis of Oxymethylene Dimethyl Ether by Homogeneous Catalysis and Uptake of Molecular Formaldehyde.

Peter A, Fehr SM, Dybbert V, Himmel D, Lindner I, Jacob E, Ouda M, Schaadt A, White RJ, Scherer H, Krossing I.

Angew Chem Int Ed Engl. 2018 Jul 20;57(30):9461-9464. doi: 10.1002/anie.201802247. Epub 2018 Jul 3.

PMID:
29893511
15.

Single Nucleotide Polymorphisms in the G-Protein Coupled Receptor Kinase 5 (GRK5) Gene are associated with Plasma LDL-Cholesterol Levels in Humans.

Lutz SZ, Falcenberg M, Machicao F, Peter A, Kächele M, Randrianarisoa E, Lehn-Stefan A, Wagner R, Machann J, Schick F, Heni M, Ullrich A, Fritsche A, Stefan N, Häring HU, Staiger H, Kantartzis K.

Sci Rep. 2018 May 17;8(1):7745. doi: 10.1038/s41598-018-26055-7.

16.
17.

Prediction of Glucose Tolerance without an Oral Glucose Tolerance Test.

Babbar R, Heni M, Peter A, Hrabě de Angelis M, Häring HU, Fritsche A, Preissl H, Schölkopf B, Wagner R.

Front Endocrinol (Lausanne). 2018 Mar 19;9:82. doi: 10.3389/fendo.2018.00082. eCollection 2018.

18.

Systemic haemodynamics in haemodialysis: intradialytic changes and prognostic significance.

Haag S, Friedrich B, Peter A, Häring HU, Heyne N, Artunc F.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1419-1427. doi: 10.1093/ndt/gfy041.

19.

Quality Control of Serum and Plasma by Quantification of (4E,14Z)-Sphingadienine-C18-1-Phosphate Uncovers Common Preanalytical Errors During Handling of Whole Blood.

Liu X, Hoene M, Yin P, Fritsche L, Plomgaard P, Hansen JS, Nakas CT, Niess AM, Hudemann J, Haap M, Mendy M, Weigert C, Wang X, Fritsche A, Peter A, Häring HU, Xu G, Lehmann R.

Clin Chem. 2018 May;64(5):810-819. doi: 10.1373/clinchem.2017.277905. Epub 2018 Mar 22.

20.

Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial.

Kantartzis K, Fritsche L, Bombrich M, Machann J, Schick F, Staiger H, Kunz I, Schoop R, Lehn-Stefan A, Heni M, Peter A, Fritsche A, Häring HU, Stefan N.

Diabetes Obes Metab. 2018 Jul;20(7):1793-1797. doi: 10.1111/dom.13268. Epub 2018 Mar 22.

PMID:
29484808

Supplemental Content

Loading ...
Support Center